Samalin Investment Counsel’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Sell
2,404
-165
-6% -$14.4K 0.07% 300
2026
Q1
$219K Sell
2,569
-58
-2% -$5.17K 0.08% 274
2025
Q4
$208K Sell
2,627
-433
-14% -$33.9K 0.07% 287
2025
Q3
$245K Sell
3,060
-246
-7% -$21K 0.08% 279
2025
Q2
$301K Sell
3,306
-48
-1% -$4.38K 0.12% 246
2025
Q1
$314K Buy
+3,354
New +$300K 0.13% 236

Other funds holding CL

Samalin Investment Counsel's CL Position: Q2 2026 in Review

Samalin Investment Counsel reduced its Colgate-Palmolive (CL) stake by 6.4% in Q2 2026, selling an estimated $14.4K and leaving 2,404 shares worth $220K. The position accounts for 0.07% of the portfolio, ranked #300.

Samalin Investment Counsel first reported a position in CL in Q1 2025 and has held it in 6 quarters since. The position peaked at $314K in Q1 2025. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Samalin Investment Counsel held 2,404 shares of Colgate-Palmolive worth $220K as of Q2 2026.
  • Samalin Investment Counsel sold 165 Colgate-Palmolive shares in Q2 2026, an estimated $14.4K.
  • Colgate-Palmolive made up 0.07% of Samalin Investment Counsel's portfolio in Q2 2026, its #300 holding.
  • Samalin Investment Counsel first reported a position in Colgate-Palmolive in Q1 2025 and has held it in 6 quarters since.
  • Samalin Investment Counsel's Colgate-Palmolive position peaked at $314K in Q1 2025.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.